戻る
Agenus Inc (AGEN)価格
AGEN 株価推移チャート
AGEN 収入
Agenus Inc
$3.34
-9.23%
$-0.34
終値： Jan 16, 16:00:00 GMT-5
$3.39
1.79%
$0.05
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$3.68
始値
$3.76
当日レンジ
$3.3 - $3.76
52週レンジ
$1.38 - $7.34
取引高
1.7M
平均取引高
648.8K
1株当たり利益(TTM)
-2.84
配当利回り
--
時価総額
$115.6M
AGENとは何ですか？
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. The company is headquartered in Lexington, Massachusetts and currently employs 316 full-time employees. The company went IPO on 2000-02-04. The Company’s pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is immuno-oncology (I-O), and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody) and balstilimab (a novel, fully human monoclonal immunoglobulin G4 (IgG4) PD-1 inhibitor). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.